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We have previously shown that prebiotics (dietary fibres that augment the growth of indigenous
beneficial gut bacteria) such as Bimuno™ galacto-oligosaccharides (B-GOSs), increased
N-methyl-D-aspartate (NMDA) receptor levels in the rat brain. The current investigation
examined the functional correlates of these changes in B-GOSs-fed rats by measuring cortical
neuronal responses to NMDA using in vivo NMDA micro-iontophoresis electrophysiology, and
performance in the attentional set-shifting task. Adult male rats were supplemented with
B-GOSs in the drinking water 3 weeks prior to in vivo iontophoresis or behavioural testing.
Cortical neuronal responses to NMDA iontophoresis, were greater (+30%) in B-GOSs adminis-
tered rats compared to non-supplemented controls. The intake of B-GOSs also partially
hindered the reduction of NMDA responses by the glycine site antagonist, HA-966. In the2017.11.001
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performance in.... European Neuropattentional set-shifting task, B-GOSs -fed rats shifted from an intra-dimensional to an extra-
dimensional set in fewer trials than controls, thereby indicating greater cognitive flexibility. An
initial exploration into the mechanisms revealed that rats ingesting B-GOSs had increased
levels of plasma acetate, and cortical GluN2B subunits and Acetyl Co-A Carboxylase mRNA.
These changes were also observed in rats fed daily for 3 weeks with glyceryl triacetate, though
unlike B-GOSs, cortical histone deacetylase (HDAC1, HDAC2) mRNAs were also increased which
suggested an additional epigenetic action of direct acetate supplementation. Our data
demonstrate that a pro-cognitive effect of B-GOSs intake in rats is associated with an increase
in cortical NMDA receptor function, but the role of circulating acetate derived from gut
bacterial fermentation of this prebiotic requires further investigation.
& 2017 Published by Elsevier B.V.1. Introduction
The link between enteric microbiota and brain function is now
widely accepted, has been considered as ‘a paradigm shift in
neuroscience’ (Mayer et al., 2014). Mice depleted of micro-
biota (germ-free mice), display altered behaviours and
reduced levels of Brain Derived Neurotrophic Factor (BDNF)
and N-methyl-D-aspartate receptors (NMDARs), which are
crucial for cognitive function (Sudo et al., 2004). Conversely,
gut microbiota enrichment with specific probiotics, live
beneficial bacteria, or prebiotics, indigestible compounds that
augment the growth of intrinsic beneficial microbes, improve
cognitive performance in rodents (Savignac et al., 2015;
Vázquez et al., 2015; O'Hagan et al., 2017) and humans
(Schmidt et al., 2015; Steenbergen et al., 2015). The reduc-
tion of attentional bias to negative emotional stimuli in
healthy volunteers following a dietary supplementation
with the Bimuno™ galacto-oligosaccharide (B-GOSs) prebiotic
(Schmidt et al., 2015), may be a corollary of increased levels
of NMDAR subunits which we have observed in the rat frontal
cortex following B-GOS feeding (Savignac et al., 2013).
However, the functional correlates of these changes have
not been explored.
The prebiotic properties of B-GOSs have been extensively
studied, and the product which contains a mixture of
galacto-oligosaccharides of several lengths (2–7 saccharides)
has been consistently shown to selectively increase Bifidobac-
teria and, to some extent, Lactobacilli in both humans
and animals (Tzortzis et al., 2005; Depeint et al., 2008;
Vulevic et al., 2008; Silk et al., 2009; Savignac et al., 2013).
Understanding how B-GOSs modulates NMDARs has important
implications for both the prevention of the age-related decline
in cognitive function (Nicolle and Baxter 2003), and the
treatment of neuropsychiatric disorders such as schizophrenia,
where aberrant glutamate neurotransmission and cognitive
deficits cannot be rescued by conventional medication. Given
that the loss of NMDAR function impairs cellular responses
in the rodent cortex (Rompala et al., 2013), we hypothesise
that the elevated cortical GluN1 and D-serine following
B-GOSs ingestion (Savignac et al., 2013), increases cortical
NMDAR-mediated neural activity, and related behaviours.
In the latter instance, based on existing data, incre-
ased cortical NMDAR function in healthy animals may
improve attentional set-shifting performance (cognitive
flexibility), a prefrontal cortex (PFC)-dependent behaviour
often impaired by NMDAR antagonists (Neill et al., 2010;B., et al., Increased cortical ne
sychopharmacology (2017), https:/Wallace et al., 2014), or the natural decrease in cortical
NMDAR levels during aging (Nicolle and Baxter 2003;
Rodefer and Nguyen, 2008). However, there are no studies
demonstrating improved cognitive flexibility in experimentally
naïve rodents following an elevation of NMDARs, and/or their
function, in the PFC. The increase of central NMDAR subunits
in the rat brain following B-GOS ingestion, provides a model to
test this.
There is also an urgent need to ascertain the mechanisms
that underlie the central effects of B-GOSs, so that key
intermediaries of microbe-brain interactions can be
revealed. The short-chain fatty acids (SCFAs) that arise from
bacterial fermentation of dietary carbohydrates in the host
gut, have been suggested to be one such mediator (Sarkar
et al., 2016). Fermentation of B-GOS has been shown to
produce significant amounts of acetate, and moderate
amounts of butyrate (Grimaldi et al., 2016, 2017). Both of
these SCFAs can have central effects, particularly at the
epigenetic level where they both influence the expression of
brain histone deacetylases (HDACs) (Soliman et al., 2012;
Han et al., 2014), but a link between metabolic acetate and
NMDARs has also been demonstrated (Hirose et al., 2009;
Singh et al., 2016). In this regard, if acetate is involved in
B-GOSs mediated changes of NMDAR function, then direct
acetate supplementation might be expected to have similar
effects on central NMDAR levels as the prebiotic itself.
The aim of the current study was to, first, confirm with
in vivo iontophoresis electrophysiology increased NMDAR
function in the rat frontal cortex following B-GOSs intake
alone, or in the presence of the NMDAR glycine-site
antagonist, HA-966. Second, test if administration of
B-GOSs facilitated cognitive flexibility, based on the pre-
biotic-mediated elevation of cortical NMDARs. Third,
explore the role of acetate in the actions of B-GOSs by
(i) measuring plasma and brain levels of this SCFA in B-GOSs
-fed and control rats, and (ii) quantifying in all animals the
expression of frontal cortex Acetyl Co-enzyme A Carbox-
ylase (ACC) mRNA. Earlier work has demonstrated that a
single systemic injection of acetate into rats increases the
activity of hypothalamic ACC (Frost et al., 2014). This
enzyme metabolises the Acetyl Co-enzyme A that is pro-
duced from the acetate sequestered in tissues. The abun-
dance of cortical ACC mRNA therefore, was used as an
indicator of acetate metabolism. In addition, the expression
of HDAC(1–4) genes in the cortex were measured to evaluate
whether B-GOSs, via acetate, affects epigenetic processes.uronal responses to NMDA and improved attentional set-shifting
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3B-GOS increases cortical NMDA responses and cognitive flexibility in ratsFinally, plasma and brain acetate, cortical GluN subunit
levels, and ACC and HDAC(1–4) mRNAs were evaluated in
glyceryl triacetate fed rats to further examine the potential
involvement of acetate in NMDAR modulation.
2. Experimental procedures
2.1. Animals
Adult male Sprague Dawley rats (250–300 g) were housed (3rats/
cage) in standard laboratory conditions (2171 1C; lights on 07:00–
19:00 h), with free access to water and standard laboratory chow.
For behavioural testing, rats had limited access to standard chow
(food restricted) and maintained at 85–90% of their free-feeding
weight throughout experiments. The nutritional content of the
standard diet provided (Envigo, USA, product no. 2916) included
protein (16%), fat (4%), crude fibre (3.3%), and insoluble fibre (eg
cellulose, 15%). All procedures were carried out in accordance with
UK Home Office Animals (Scientific Procedures) Act (1986) and
associated Home Office guidelines. The procedures specific to this
study were approved by the local Animal Welfare and Ethical
Review Body (AWERB) at both DeMontfort and Oxford Universities.
2.2. Prebiotic administration
Rats received normal drinking water, drinking water supplemented
with 3% B-GOSs, or drinking water supplemented with B-GOSs free
sugars (BFS: lactose [7.5 g/L], glucose [4.2 g/L] and galactose
[3.6 g/L]) for 3 weeks and throughout behavioural tests. The
inclusion of a BFS group was to determine whether any behavioural
effects of B-GOSs was attributable to the ingestion of the sugars in
the prebiotic mixture, rather than the galato-oligosaccharides.
Body weight and fluid intake in all groups were recorded every
2 days. Food restriction for behavioural studies commenced 7 days
after the provision of prebiotic.
2.3. Glyceryl triacetate administration
In a separate study male rats (250–300 g) were gavaged with
glyceryl triacetate (GTA, 1 g/ml, Sigma Aldrich, UK) at a final dose
of 3 g/kg, or the same volume of water alone (control) daily for
3 weeks. The choice of GTA dose and control was based on a
previous studies (Singh et al., 2016).
2.4. In vivo iontophoresis electrophysiology
These experiments were conducted on B-GOSs-fed rats and water
controls as previously described (Di Miceli and Gronier, 2015). Animals
were deeply anaesthetised with urethane (1.2–1.7 g/kg, intraperito-
neal, with additional doses if necessary), secured to a stereotaxic frame
and maintained at 36–37 1C. Briefly, under urethane anaesthesia,
animals underwent stereotaxic surgery to drill a hole in the skull over
the PFC (co-ordinates from Bregma: anteroposterior + 2.5–3.7 mm,
lateral 0.3–2 mm). Five-barrel glass micropipettes (ASI, USA), pulled on
a PP-830 electrode puller (Narishige, Japan) were used. The central
barrel, filled with a saline solution, was used for recording, and the
four-side barrels were filled with at least one of the following solutions:
NMDA (30 mM in 200 mM of NaCl, pH 7.5), HA-966 (10 mM, in 200 mM
NaCl, pH 4) and 1 M NaCl for current balancing (later found to be
unnecessary).
Outputs from the electrode were sent to a Neurolog AC pre-
amplifier and amplifier (Digitimer, UK). Signals were filtered and sent
to an audio amplifier, a digital storage oscilloscope and a 1401
interface connected to a computer running Spike 2 (CED, Cambridge,Please cite this article as: Gronier, B., et al., Increased cortical ne
performance in.... European Neuropsychopharmacology (2017), https:/UK) for data capture and analysis. Descent of the electrode was
accomplished using a hydraulic micromanipulator (Narishige). Coordi-
nates for the PFC were as follows: anteroposterior 2.5–3.7 mm, lateral
0.3–2 mm, 1.5–5 mm below cortical surface. Neurons were identified
according to previous electrophysiological criteria established from
studies carried on formally identified pyramidal neurons (Hajos et al.,
2003; Puig et al., 2005; Tseng et al., 2006; Kargieman et al., 2007;
Gronier 2011; Wang et al., 2011): a broad action potential (41 ms),
with a biphasic or triphasic, large waveform, starting with a positive
inflection, a slow firing rate typically between 1 and 50 spikes/10 s and
irregular firing pattern, often with burst activity.
Neuronal response was measured by the software (Spike 2,
Cambridge Electronic design) as actions potentials (number of
spikes) generated both at baseline and in response to drugs
injections, from a neuron per 10 seconds. All data were expressed
as a net response relative to baseline recordings. NMDA or AMPA
were ejected as cations by applying a negative current at a given
intensity (1 to 15 nA) for 40–70 s at 70–100 s interval. HA-966 was
ejected as an anion by applying a positive current (3 to 35 nA)
during a long-lasting stable (4200 s) neuronal activation elicited by
NMDA or AMPA application. Drugs were retained in the iontophoretic
channel by applying a low intensity current (2–5 Na) of opposite
charge of the ejection current.2.5. Attentional set-shifting task (ASST)
This task was carried out on B-GOSs supplemented rats and water
controls using an established procedure (Burnham et al., 2010). The
testing chamber was a home cage with Perspex dividers separating
the cage into a start chamber and two identically sized choice
chambers with access controlled by Perspex doors. Ceramic bowls
were placed within the choice chambers and baited with pieces of
sweetened cereal (Honey Nut Cheerios, Nestle, Surrey, UK). A piece
of cereal was also placed at the bottom of each bowl to mask the
odour of the bait, and was protected by a fixed wire mesh to make
it inaccessible to rats. During testing, one bowl was baited and rats
discriminated the baited bowl using the texture and/or the odour of
the digging medium. Choice was defined as active digging or
foraging with the snout in the digging medium. Rats were habitu-
ated to the apparatus and initially taught to dig in baited bowls
filled with home cage bedding. On the day prior to testing, rats
performed two simple discriminations, one based on odour (laven-
der versus lemon scented bedding) and one based on medium (small
wooden beads versus large wooden beads), to a criterion of six
consecutive correct trials. The order of training discriminations
(odour/medium) and the rewarded odour and digging medium were
counter-balanced, and exemplars (Table 1) were not used again
throughout testing.
All the discriminations in the testing sequence were presented in
a single test day. The first four trials of each discrimination were
“discovery” trials, during which the rat was allowed to dig in
medium both bowls, to discover which bowl contained the reward.
An error was recorded if the rat dug first in the unbaited bowl, but
these trials were not included in the trials or errors to criterion
score. After the first four trials, if the rat dug in the unbaited bowl,
an error was recorded and access to the correct bowl was denied.
The rat was allowed to return to the start chamber of its own
accord to start the next trial. Testing continued until the rat
reached a criterion of six correct consecutive trials. The sequence
and composition of several discriminations used in the test are
summarized in Table 1. A simple discrimination (SD), between
either two odours or two digging mediums, was followed by a
compound discrimination (CD) which had the same positive stimulus
as the SD, but included a new irrelevant dimension which did not
predict the location of the reward. This was followed a reversal of
the CD (R1) where all of the stimuli remained the same, and theuronal responses to NMDA and improved attentional set-shifting
/doi.org/10.1016/j.euroneuro.2017.11.001
Table 1 Discrimination phases of the attentional set-shifting task and exemplars. Rewarded exemplars are underlined.
Discrimination Odour pair Medium pair
Simple discrimination cinnamon/cumin Bedding
Compound discrimination cinnamon/cumin cat litter/ground cat litter
Reversal 1 cinnamon/cumin cat litter/ground cat litter
Intra-dimensional shift clove/thyme pebbles/gravel
Reversal 2 clove/thyme pebbles/gravel
Extra-dimensional shift mint/paprika sawdust/shavings
Reversal 3 mint/paprika sawdust/shavings
B. Gronier et al.4relevant dimension remained the same, but the rewarded and non-
rewarded stimuli within the dimension were reversed. The rats
were then subjected to an Intra-dimensional (ID) shift which was a
CD in which both the relevant and irrelevant stimuli changed, but
the rewarded dimension (either odour or medium) remained the
same. This was followed by a second reversal (R2) stage as
described for R1. The rats were then exposed to an extra-dimen-
sional (ED) shift, where the relevant and irrelevant stimuli changed,
as well as the relevant dimension, so if odour had previously
predicted the location of the reward, the digging would become
the relevant dimension. A third reversal (R3) followed the ED, as
described for R1 and R2. The experimenter was blind to treatment
and remained in the experimental room silently during experiments
for live scoring. Animals were tested in a controlled, random
fashion regarding cage and treatment groups, and then were
returned to their home cage where provision of prebiotic or control
solutions continued. All rats were humanely culled 24 h after
behavioural testing.2.6. Blood and tissue collection
On completion of all experiments rats were culled and the trunk
blood collected in sterile 2 ml heparin-coated Eppendorf tubes.
Samples were centrifuged for 5 min in a bench-top centrifuge at
maximum speed, the plasma was removed and stored at 80 1C
prior to acetate assays. The frontal cortex was cut from cerebrum,
bisected and stored at 80 1C prior to use. Faecal pellets were also
collected from all rats that had been subjected to the ASST, and
frozen at 80 1C prior to DNA extraction.2.7. Western blotting
One hemisphere of the frontal cortex from each group of rats was
homogenised in RIPA buffer (Sigma-Aldrich, UK), and run on western
blots as previously described (Savignac et al., 2013). Equal con-
centrations of protein extracts of the cortex (10 ug) from all groups
(n=8 rats/group) were mixed with loading buffer (50 mM 1,
4-dithiothreitol and 0.025% bromophenol blue), and fractionated
with a molecular weight marker (GE Healthcare, Buckinghamshire,
UK) by electrophoresis on pre-cast 7.5% SDS/polyacrylamide gels
(Biorad,UK), and trans-blotted onto polyvinyl difluoride (PVDF)
membranes (Immobilon-P, Millipore, Watford, UK).
The membranes were blocked with 5% (w/v) non-fat milk in PBS
containing 0.1% Tween20 (PBST) for 45 min, and then incubated for
1 h at room temperature in incubation buffer (PBST with 2% [w/v]
milk) containing a primary antibody (diluted 1:1000) against one of
three NMDAR subunits: GluN1 (AB9864, Millipore, UK), GluN2A
(AB1555, Millipore, UK) and GluN2B (AB15362, Millipore, UK), and
β-actin (Sigma-Aldrich, UK, diluted 1:500,000). Membranes were
then washed three times for ten minutes in PBST and incubated forPlease cite this article as: Gronier, B., et al., Increased cortical ne
performance in.... European Neuropsychopharmacology (2017), https:/30 min in HRP-linked secondary antibody in blocking buffer. Immu-
noreactive bands were visualized by chemiluminescence using the
ECL-Plus kit (GE Healthcare, Buckinghamshire, UK), and apposing
membranes to X-ray film (Kodak BioMax AR film). All antibodies
produced a single band of expected molecular weight. The optical
densities (OD) of bands were measured using the AlphaImager 3400,
and the data expressed as OD ratios of NMDAR subunit:β-actin.2.8. Extraction of cortical RNA and faecal DNA, and
quantitative PCR (QPCR)
Total RNA was extracted from the remaining fragment of cortical
tissue using Tri-Reagent according to manufacturer's instructions,
and reverse-transcribed to cDNA, using a commercial kit (Life
Technologies, UK). The SYBR Green methodology (Power SYBER,
Life Technologies, UK) was used to quantify the expression of
mRNAs encoding Acetyl Co-Enzyme-A Carboxylase (ACC) and HDAC
(1-4) in all cortical cDNA preparations. The amplification of ACC was
achieved using forward (5'-GCT GAA GTC CCT GGA TCA CC-3') and
reverse (5'-CTT TTA CAG CAC ACT GTT CC-3') primers that spanned
1012-1228 base-pairs of the rat ACC gene (NM_022193.1). QPCR of
HDAC(1-4) mRNAs used previously published primers (Han et al,
2014).
Bacteria DNA from faecal samples was extracted using QIAamp
DNA Stool Mini Kit (Qiagen, Hilden, Germany) after mechanical
disruption. The abundance of 16S DNA encoding specific microbial
genera and total bacteria in faecal pellets were analysed using
qPCR and previously published primers (Morel et al., 2015). The
SYBR Green methodology was used to amplify 20 ng DNA. All QPCR
assays were performed on a 7900HT Fast Real-Time PCR System
(Applied Biosystems, USA).2.9. Acetate assay
The concentration of acetate in plasma and cortical homogenates
were measured using a commercial colorimetric assay (ab204719,
Abcam, UK). Prior to all assays, plasma and RIPA extracts of frontal
cortex (see above) were thawed and 50 μl were aliquoted into1.5
ml Eppendorf tubes. An equal volume of isopropanol was then
added to all samples and thoroughly mixed to precipitate proteins.
Tubes were centrifuged on a bench-top centrifuge for 5 min at
maximum speed, and the supernatant was transferred to a fresh
tube. All samples were dried down and the anhydrous metabolites
dissolved in 50 μl acetate buffer. Ten microliters of protein-free
plasma and cortical extracts were assayed for acetate in duplicate
with a standard curve according to manufacturer's instructions.uronal responses to NMDA and improved attentional set-shifting
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5B-GOS increases cortical NMDA responses and cognitive flexibility in rats2.10. Data analysis
Normal distribution of data was confirmed using Shapiro-Wilk test
(SPSS, ver.22). All data are expressed as mean 7 standard error of
the mean (SEM). Electrophysiological, behavioural body weight and
fluid intake data were analysed with Two-way ANOVA (repeated
measures), and Bonferroni post-hoc correction. All QPCR data are
presented as fold change (relative to GAPDH for tissue, and total
bacterial 16S for faecal DNA) which were calculated using the
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Fig. 1 The effects of B-GOS supplementation on NMDA iontophore
firing rate histograms showing the individual responses to the iont
neurons from the water and the B-GOS group. Each top horizontal
induced transient neuronal activation. (B) Cortical mean neuronal
15 nA, in B-GOS-fed and control animals. There were no group x cu
neuronal responses were greater in B-GOS rats compared to contr
(controls); n=44 (B-GOS).
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performance in.... European Neuropsychopharmacology (2017), https:/Acetate concentrations were also calculated as fold-change relative
to control group (experimental or control value/mean control
value) so that plasma and brain acetate changes could be compared
to brain ACC levels. All western blot OD ratios, and QPCR and
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ols at all currents (nA). *po0.05 compared to controls. n=36
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B. Gronier et al.63. Results
3.1. Effect of B-GOSs intake on cortical NMDA
responses
In the first iontophoresis experiment, a total of 36 and 44
neurons in the control and B-GOSs groups, respectively,
were included (6–10 neurons per rat tested). All neurons
tested exhibited the electrophysiological characteristics of

























Fig. 2 Cortical NMDA responses to HA-966 in B-GOS fed rats and c
histograms in response to iontophoretic applications of NMDA and HA
shows that HA-966 more potently reduced the firing activation elicite
neuron from the B-GOS fed rats. The NMDA pulses applied in the abse
neuronal responses were not influenced by preceding antagonist appl
to iontophoretically applied HA-966, at a fixed current of NMDA (
neuronal activation), decreased in both B-GOS and control rats. At 
in B-GOS rats compared to controls. (C) Inhibitory dose response cur
water and B-GOS rats. *po0.05, univariate analysis of group effect
Please cite this article as: Gronier, B., et al., Increased cortical ne
performance in.... European Neuropsychopharmacology (2017), https:/(see above). Neurons from both B-GOSs and water groups
had similar low basal firing activity (12.672.6 and 7.771.2
Spikes/10 s for B-GOSs and water groups, respectively,
p40.05), and more than 60% of the tested neurons from
both groups had virtually no basal firing activity (firing rate
o4 spikes/10 s). Iontophoretic application of NMDA, applied
at currents between 5 and 10 nA, (Fig. 1A) produced a
current dependent increase in firing activity, from baseline
levels by 10–30 additional spikes/10 s per 5 nA of NMDA
applied. However, the response plateaued at the highest


















ontrols. (A) Individual activity traces (top panel) and firing rate
-966, of two representative neurons from each group. The figure
d by NMDA in the neuron from the control group compared to the
nce of HA-966 at the end of the experiment, demonstrated that
ications. (B) Burst activity traces (top panel) and mean responses
typically between 5–10 nA, enough to produce a stable 4–5 HZ
25 nA of HA-966, the NMDA response was less efficiently reduced
ves showing the effect of HA-966 on NMDA cortical responses in
in 2-Way ANOVA (repeated measures); n=16/group.
uronal responses to NMDA and improved attentional set-shifting
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Fig. 3 Neuronal responses to HA-966 alone and with ionto-
phoretic application of NMDA and AMPA. (A) Representative
traces (top panel) and neuronal response profile showing that
application of HA-966 does not affect basal activity or subse-
quent NMDA responses after terminating its application. The
latter confirms that HA-966 removal is rapid when its applica-
tion is stopped. (B) Representative electrophysiological profile
showing that HA-966 iontophoresis inhibits NMDA, but not
AMPA, neuronal responses at 15 nA. (C). High concentrations
of HA-966 applied to neurons (at similar current intensities used
for inhibition of NMDA responses) does not affect neuronal
activity in the cortex compared to controls (3 nA, n=17).
7B-GOS increases cortical NMDA responses and cognitive flexibility in rats
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performance in.... European Neuropsychopharmacology (2017), https:/response obtained at 10 nA. This effect is probably due to
saturation of NMDA receptors and/or partial depolarisation-
inactivation, as some neurons tend to depolarise when
currents higher than 10 nA were applied. Only neurons
which produced consistent neuronal activations at a given
current over time were selected. At all currents tested, the
mean neuronal responses to iontophoretic NMDA in the PFC
were greater in B-GOSs -fed rats relative to controls
(F1,78=7.01, p=0.011) (Fig. 1B). There was no diet x
current (NMDA) interaction (F2, 156 = 0.99, p40.05).
In another experiment, the ability of the NMDAR glycine
site antagonist, HA-966, to reduce the response of neurons
to NMDA was tested. A long lasting application of NMDA
(410 min) at low currents (5 to 10 nA), was sufficient to
produce a stable level of mild activation (40–75 spikes/10 s)
during which HA-966 was applied at various currents at 30–
50 s intervals (Fig. 2). The iontophoretic application of HA-
966 to cortical neurons inhibited NMDA-mediated responses
at all currents tested (5 to 25 nA), in a current-dependent
manner in both B-GOSs and control animals (Fig. 2A).
A diet x current (HA-966) interaction was not observed
(F3,90=1.15, p40.05), although there was an effect of
group (F1,30=4.91, p=0.037). This was driven by the greater
magnitude of the NMDA-mediated response in B-GOSs rats
at 25 nA HA-966 compared to controls (p=0.013)
(Fig. 2B). These data when plotted as % Response, (net
response with HA-966/net response no HA-966 *100), con-
firmed that B-GOSs reduced responses at 25 nA without
shifting the inhibitory dose response curve relative to the
water group (Fig. 2C).
To test whether HA-966 interacted with sites other than
the NMDAR glycine binding site, neurons were exposed to
the inhibitor in the absence of NMDA stimulation (Fig. 3).
Histograms in Fig. 3A show that HA-966 applied at 15 nA
did not affect baseline responses. The uninterrupted admin-
istration of NMDA before and after HA-966 application,
revealed full recovery of the NMDA response after the
cessation of antagonist application, and so confirmed that
the selected neurons were fully responsive to NMDAR
stimulation and that this response was sensitive to HA-
966. Although neurons were also responsive to AMPA, AMPA-
dependent activity was not blocked by HA-966 (Fig. 3B).
This lack of effect of HA-966 toward AMPA-induced activity
verified the specificity of the effect of HA-966 for NMDAR.
3.2. Effect of B-GOS on ASST performance, body
weights, fluid intake and faecal Bifidobacterium Spp.
The administration of B-GOSs improved ID/ED set shifting in
the ASST paradigm, whereas rats provided with BFS per-
formed worse than rats provided with normal drinking water
(Fig. 4A). A significant diet  discrimination interaction
(F12,162=4.43, p=0.001) was observed which was attributa-
ble to the effect of both B-GOSs and BFS on ED performance
relative to controls (F2,27=24.78, po0.001). Post hoc analy-
sis with Bonferroni correction revealed that B-GOSs -fed rats
required fewer trials to reach criterion in the ED discrimina-
tion task compared to controls (p=0.003), whereas the BFS
supplemented rats required significantly more trials to reach
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Fig. 4 Attentional set-shifting performance, body weight and
fluid intake in water, BFS and B-GOS rats. (A) The intake of
B-GOS reduced the number of trials required to complete the
ED phase to criterion, compared to controls. The significant
difference between the number of trials in ID and ED seen with
control rats, was not observed for B-GOS fed animals. Rats
supplemented with BFS required more trials to criterion for ED
compared to animals that had received standard drinking water
or B-GOS. (B) Body weight of BFS-fed rats were significantly
greater than controls during attentional-set shifting tasks.
Arrow indicates the start of food restriction to obtain 85% of
body weight for task performance. (C) Fluid intake by BFS-fed
rats was significantly greater than controls 4 days after the
start of supplementation and throughout the study. All data
were analysed with 2-Way ANOVA (repeated measures).
*po0.05 compared to controls; #po0.001 compared to ID
phase; 1 po0.001 compared to BFS; n=12/group.
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between ID and ED performance in control (F1,24=30.49,
po0.001) and BFS (F1,24=83.91, po0.001) groups was not
observed for B-GOSs rats (F1,24=2.03, p40.1), and indicated
improved ID/ED set-shifting, thus cognitive flexibility, in
these animals.
The analysis of average changes in body weight through-
out the supplementations and duration of the behavioural
experiments did not reveal a diet  weight  time
interaction, but showed a significant effect of diet
(F50,702=49.04, po0.001). This was driven by the elevation
of body weight in BFS rats relative to controls (po0.01)
primarily on days 34–50, following food deprivation for ASST
experiments (Fig. 4B). No significant differences in body
weight were observed between controls and B-GOSs rats
(p40.05). The analysis of fluid intake also revealed a
significant effect of group (F50,702=173.98, po0.001),
which was attributed to the BFS rats drinking significantly
more than controls (po0.001) from days 4–50 (Fig. 4C). The
intake of B-GOSs supplemented water was not different to
the consumption of water alone (p40.05).
The QPCR analysis of Bifidobacterium Spp. in faecal DNA
from rats subjected to ASST revealed a significant difference
between groups (F2,21=5.043, p=0.021). The fold-change in
bacteria in the B-GOS fed animals was approximately two-
fold greater than the other groups (Means7SEM of
Water=0.9970.36; BFS=0.9070.30; B-GOSs=2.4570.47;
po0.05, Water vs B-GOSs and BFS vs B-GOSs groups).3.3. Effects of B-GOSs or GTA supplementation on
GluN subunits, plasma and cortical acetate, and
cortical ACC, HDAC1 and HDAC2 mRNAs
Western blot analysis of cortical tissue from rats (Fig. 5A)
demonstrated a significant elevation of GluN2B in the
B-GOSs group compared to controls (F1,20=6.13,
p=0.036). To explore the possibility that increased circulat-
ing acetate could influence NMDAR subunit expression,
GluN subunits were measured in rats gavaged daily with
GTA for 3 weeks. A significant increase of cortical GluN1
(F1,20=8.32, p=0.018), and GluN2B (F1,20=6.32, p=0.033)
subunits were observed in GTA fed rats compared to
controls (Fig. 5B).
Plasma acetate concentrations (F1,20=6.98, p=0.019)
and the abundance of cortical ACC mRNA (F1,20=6.7,
p=0.021), were also elevated by B-GOSs supplementation,
(Fig. 5C). The levels of cortical acetate did not alter with
B-GOSs feeding relative to controls. Similarly, cortical ACC
mRNA abundance increased (F1,20=8.83, p=0.01), following
GTA supplementation, and this was paralleled by an
approximately 3-fold elevation of plasma acetate levels
(F1,20=13.24, p=0.006), (Fig. 5D). No changes in cortical
acetate levels were observed in these rats.
The intake of B-GOSs for 3 weeks did not affect HDAC (1–4)
gene expression in the frontal cortex (Fig. 6A). However, GTA
administration elevated both HDAC1 (F1,20=5.01, p=0.049) and
HDAC2 (F1,20=5.09, p=0.048) mRNAs (Fig. 6B). Cortical HDAC3
and HDAC4 mRNA abundance remained unaltered following GTA
supplementation.uronal responses to NMDA and improved attentional set-shifting
/doi.org/10.1016/j.euroneuro.2017.11.001
Fig. 5 Effect of B-GOS or glyceryl triacetate (GTA) supplementation on rat cortex GluN subunits, acetate concentrations and acetyl
Co-A carboxylase (ACC) gene expression. (A) Western blots demonstrated increased levels of cortical GluN2B subunits in B-GOS
supplemented rats compared to controls. (B) A daily, 3 week administration of GTA (3 g/kg) increased cortical GluN1 and GluN2B
levels. (C) In B-GOS fed rats, plasma acetate levels and cortical ACC gene expression were increased relative to controls, whereas
cortical acetate levels remained unaltered. (D) GTA supplementation elevated plasma, but not brain, acetate concentrations and
ACC mRNA. *po0.05 compared to controls; n=8/group.
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Maintaining healthy cognitive function has become one of
the major challenges, both for neuropsychiatric disorders
and healthy ageing in which optimal activity of the NMDAR is
crucial. We have previously demonstrated that B-GOSs
intake by adult rats elevated cortical GluN1 subunits and
its co-agonist, D-serine (Savignac et al., 2013). The current
study investigated the functional correlates of these altera-
tions by measuring cortical NMDAR responses and cognitive
flexibility in B-GOSs fed rats, and found increased neuronal
responses to iontophoretically applied NMDA, and improved
ID/ED set shifting in B-GOSs supplemented animals com-
pared to controls. Additional experiments suggest that
acetate, a metabolite of B-GOSs fermentation, might bePlease cite this article as: Gronier, B., et al., Increased cortical ne
performance in.... European Neuropsychopharmacology (2017), https:/involved in the elevation of NMDAR subunits following
prebiotic intake. Overall, these data confirm that B-GOSs
influences NMDAR function, though the interpretation some
specific findings require careful consideration.
The increased magnitude of NMDA-mediated responses
following B-GOSs intake compared to controls in the PFC,
suggests elevated cortical NMDAR function. Our current
observations, therefore, are in-keeping with our previous
finding of increased GluN1 subunits in the cortex of B-GOSs-
fed rats (Savignac et al., 2013). Since in that study, B-GOSs
feeding also elevated cortical D-serine, and in other work
increased synaptic concentrations of NMDAR co-agonists
hindered the dampening effects of HA-966 on NMDAR
activity in rats (Chen et al., 2003), we tested if B-GOS
































Fig. 6 Effect of B-GOS or glyceryl triacetate (GTA) supple-
mentation on rat cortex HDAC1-4 mRNAs. (A) B-GOS supple-
mentation did not affect the expression of HDAC genes. (B) A
daily, 3 week administration of GTA (3 g/kg) increased cortical
HDAC1 and HDAC2 mRNAs, but not HDAC3 and HDAC4. *po0.05
compared to respective controls; n=8/group.
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reduced the NMDA-evoked responses in both controls and
B-GOSs-fed rats, and suggests that prebiotic supplementa-
tion did not hinder HA-966 binding to the NMDAR. However,
B-GOSs did influence the magnitude of the NMDA response
at the highest concentration of HA-966 (25 nA, Fig. 2B),
relative to controls. Plotting these data as an inhibition
dose response curve (Fig. 2C) not only confirmed the
significant B-GOSs effect at the highest concentration of
inhibitor, but also revealed that both the prebiotic and
control inhibition curves overlapped at the lower HA-966
concentrations. This argues against additional populations
of GluN1 subunits or higher D-serine levels following
B-GOSs intake in the present investigation.
Increased levels of GluN1 subunits and/or D-serine rela-
tive to controls would be expected to cause a right-ward
shift in the HA-966 inhibitory curve because, higher con-
centrations of the antagonists would be required to occupy
the additional subunits and/or compete with higher synap-
tic concentrations of D-serine, and since this was absent
after B-GOSs intake the elevation of cortical GluN1 sub-
units (or D-serine) in this study can be ruled out. Indeed,
western blots of rat cortical tissues revealed that thePlease cite this article as: Gronier, B., et al., Increased cortical ne
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pared to controls (Fig. 5A). This suggests elevated NMDAR
function via increased GluN2B-containing populations of
receptors and may explain a group difference at the highest
HA-966 concentration. That is, lower concentrations of HA-
966 may have been blocking a majority of NMDARs compris-
ing of GluN2A subunits which are also abundant in the
cortex, but when these became saturated the observed
NMDA responses arose from the GluN2B containing recep-
tors, which have different (slower) functional kinetics to
the GluN2A moieties (Monaco et al., 2015). Of course, the
differential responses between B-GOSs and control groups
may also suggest that the high antagonist concentrations
might be binding to extraneous non-NMDAR sites. However,
the demonstration that neither HA-966 alone nor in the
presence of other excitatory stimuli (AMPA, Fig. 3) influence
neuronal responses, confirms that the inhibitor was only
targeting NMDARs. Future work into the mechanisms of
B-GOSs central actions might explore the involvement of
other neurotransmitter systems such as GABA, which have
been implicated in both the mediation of microbiome-gut-
brain communication (Sarkar et al., 2016) and the modula-
tion of cortical neural activity (Puig et al., 2005).
It is clear from the current electrophysiological experi-
ments that B-GOSs ingestion elevates cortical NMDAR
function in rats, and from our previous studies, this does
not seem to be mediated by changes in the concentration of
peripheral or central glutamate itself (Savignac et al.,
2013). However, the initial changes on which our present
hypothesis was based ie elevated cortical GluN1, was not
observed. One possible explanation is the method of pre-
biotic administration where in our original experiments rats
were gavaged, but in the present study B-GOSs was
provided via their drinking water. The gavage technique is
known to be stressful (Gonzales et al., 2014), and although
control animals received the same manipulation in our
earlier investigation, the procedure may have affected
pre-existing levels of NMDAR subunits. The expression
of total GluN1 is significantly reduced by stress
(Yuen et al., 2012) and so if this occurred in our first study
(Savignac et al., 2013) and B-GOSs attenuated this effect,
it would have been observed as an increase in these subunits
relative to controls. This of course is speculative and
the possibility that specific prebiotic feeding regimens
lead to differential neurobiological outcomes would require
further investigation.
Our data provide further evidence for the cognitive-
enhancing effects of a non-pharmacological intervention
that is known to proliferate beneficial gut bacteria (see also
Burokas et al., 2017). The improvement in attentional set-
shifting is consistent with our demonstration of improved
attentional vigilance in healthy volunteers supplemented
with B-GOSs (Schmidt et al., 2015), and suggests that the
prebiotic has a significant influence on cortical-mediated
processes. Other evidence for the influence of beneficial gut
bacteria on cortical function and cognitive processes has
also been provided by some probiotic studies (Steenbergen
et al., 2015; Tillisch et al., 2013; Carlson et al., 2017). We
have also considered how the sugar content of B-GOSs may
have influenced behaviour. Studies subjecting rodents touronal responses to NMDA and improved attentional set-shifting
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memory following a daily, 4 week administration of a 10%
sucrose solution which also increased fluid intake (Kendig
et al., 2013). Since the B-GOSs solution provided to the rats
contained only 0.42% glucose (or 1.53% of total sugars, see
Experimental procedures), it seems unlikely that the intake
of the sugars in the B-GOSs formulation would influence
behaviour at all. However, it is clear from our behavioural
experiments that B-GOSs sugars (BFS) impaired perfor-
mance on the attentional set-shifting task (Fig. 4A). In this
instance, the increased fluid intake with BFS, probably due
to increased palatability of the solution in the absence of
oligosaccharides, may have induced satiety and impaired
the drive to find the food reward. Whatever the reason, it
would appear that BFS is not an appropriate control for
B-GOSs when provided in the drinking water.
The B-GOSs induced augmentation of cortical NMDAR
electrophysiological responses, and improved set-shifting
performance, provides further compelling evidence for the
influence of supplements that proliferate beneficial gut
bacteria, on central glutamate neurotransmission and their
pro-cognitive effects. A deficit in attentional set-shifting
abilities (behavioural responses to changes in environmental
cues), is observed in schizophrenia (Pantelis et al., 2009), a
disorder that has been associated with NMDAR hypofunc-
tion. In rats, the central NMDAR has been shown to be
crucial for normal ASST performance, since its pharmacolo-
gical blockade (Neill et al., 2010) or age-related reduction
in the brain (Nicolle and Baxter 2003), hinders an
animal's capacity to readily shift between two dimen-
sions in the discrimination task. Improved ID/ED set-
shifting in experimental models of NMDAR-impairment,
has been achieved with nicotinic acetylcholine receptor
agonists (Wood et al., 2016), or an opioid antagonist
(Wallace et al., 2014), but the direct influence of increased
NMDAR function on ASST performance in healthy rats has
not been reported.
The next part of the study was to test the theory that the
SCFA, acetate, a major microbial metabolite of B-GOSs
(Grimaldi et al., 2016), is involved in the modulation of
cortical NMDAR levels. This was based on a recent report
showing that acetate supplementation attenuated the
molecular effects of NMDAR blockade by MK801 (Singh
et al., 2016). We have demonstrated for the first time that
B-GOSs supplementation elevated circulating acetate con-
centrations and the cortical expression of ACC mRNA, which
parallels the observed changes in these parameters follow-
ing GTA administration. Importantly, since both interven-
tions also elevated cortical GluN2B levels it is very plausible
that acetate is a mediator of the psychotropic actions of
B-GOSs. The additional elevation of GluN1 after GTA
feeding, albeit also observed after B-GOSs in an earlier
study (Savignac et al., 2013), may either be related to the
method of administration as discussed above, and/or the
relatively greater levels of acetate arising from its direct
administration. The latter possibility may also explain the
differential effects of B-GOSs and GTA on the expression of
brain HDACs, but the key implication of these data is that
epigenetic changes are not essential for B-GOSs-mediated
central effects.Please cite this article as: Gronier, B., et al., Increased cortical ne
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brain levels of Acetyl-CoA (Bhatt et al., 2013) and may
have been the cause of elevated ACC gene expression
following B-GOSs and GTA intake ie increased ACC is a
homeostatic response to normalize levels of its substrate
generated from free acetate. However, the concentration of
brain acetate is also modulated by its uptake, which can be
hindered by NMDARs (Hirose et al., 2009). Therefore, our
observed elevation of cortical GluN2B levels and NMDAR
function after B-GOSs feeding could also be interpreted as
a homeostatic response to elevated circulating acetate.
Thus, the reduced uptake of acetate through elevated
NMDAR activity together with increased levels of ACC might
explain the unaltered levels of brain acetate after B-GOSs
(Fig. 5B) or GTA (Fig. 5D).
Indirect evidence for increased central metabolism
underlying the actions of B-GOSs on the brain was the
finding that HDAC gene expression remained unaltered after
prebiotic feeding, which excluded the involvement of
acetate-mediated epigenetic effects. We have confirmed
the elevation of HDAC1 and HDAC2 following GTA (Soliman
et al., 2012, and see Fig. 6) at the level of encoding mRNA
which supports data showing that direct acetate supple-
mentation does influence central epigenetic pathways. It is
noteworthy that GTA-mediated attenuation of MK801
effects, involved increased brain histone acetylation and
activation of NMDAR-independent signalling. Our current
finding may indicate, therefore, that circulating acetate
levels following B-GOSs ingestion activate NMDAR mediated
processes whereas the higher concentrations that arise from
GTA supplementation, trigger additional epigenetic pro-
cesses. This interpretation of our findings would require
testing by performing GTA dose response experiments and
measuring NMDAR function and brain histone acetylation.
Furthermore, changes in HDAC activity would also be
important to assess since this may alter independently of
encoding mRNA eg via post-translational phosphorylation
(Singh et al., 2016).
It should be emphasized that this study only focussed on
the involvement of acetate because it is a major metabolite
of B-GOSs and has been linked to NMDARs (Hirose et al.,
2009; Singh et al., 2016). Moreover, the detection of
circulating acetate is easily achieved using rapid, commer-
cially available kits that can be used for subsequent human
trials. Of course, acetate is not the only SCFA that results
from microbial fermentation of B-GOSs. Increased enteric
butyric acid following B-GOSs intake (Grimaldi et al., 2016,
2017) has significant effects on the gut epithelium
and may influence central functions via the establi-
shed routes (eg immunity) of the gut-brain axis
(Stilling et al., 2016). Moreover, butyrate directly affects
central gene expression via epigenetic mechanisms
(Han et al., 2014; Stilling et al., 2016). Thus, the effect
of this SCFA on brain HDAC activity/protein phosphorylation
status following the administration of butyrate would have
to be analysed to completely rule out the role of this
metabolite in the central actions of B-GOSs.
Finally, it is important to note that a recent study using
another formulation of GOS and in combination with a
fructo-oligosaccharide (FOS), demonstrated psychotropic
effects but did not reveal an association between acetateuronal responses to NMDA and improved attentional set-shifting
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et al., 2017). In the light of our present data, this may
suggest that acetate may have region specific effects.
However, the study also demonstrated a reduction of
Bifidibacteria and Lactobacilli with the FOS and GOS
formulations whereas we have reported the increase in
the former with B-GOSs (Savignac et al., 2013, 2016); this
indicates that even the primary actions of these prebiotics
are different. Of course, it would be naïve to conclude that
the modulation of brain function solely depends on changes
in the levels of just two genera of bacteria given the
vastness of the gut microbiome, but the discrepancies do
emphasise that our findings with B-GOSs are only applicable
to this specific prebiotic mixture, and cannot be extended
to all formulations of GOS. The current study used B-GOSs
because it is readily available to the consumer (Bimuno™,
for composition see Vulevic et al., 2008), and its bifidogenic
actions in animals and humans have been well documented
(see above). Future mechanistic and functional studies with
other prebiotics therefore, will need to consider not only
animal species and appropriateness of tests for different
brain regions, but also the formulation and principal effect
of the compound under investigation.
In conclusion, the current study provides an original
demonstration of elevated cortical NMDAR responses and
improved cognitive flexibility following B-GOSs intake. A
potential mechanism has also been proposed where
increased circulating acetate that results from B-GOSs
metabolism may affect NMDAR neurobiology via metabolic
pathways rather than through direct influences on epige-
netic mechanisms that modulate gene expression. Supple-
menting rats directly with acetate provided this initial
proof-of-concept, but additional experiments are required
to confirm whether changes in NMDAR subunit levels after
GTA have similar functional actions as B-GOSs feeding. One
important implication of our findings is that the ingestion of
B-GOSs in adulthood may offer ‘neuroprotection’ and limit
age-related deterioration of NMDAR and cognitive function.
Another possibility is that B-GOSs might be used as an
adjunctive therapy in neuropsychiatric disorders such as
schizophrenia, depression, or dementia, where cognitive
deficits are a prominent feature of these illnesses, and do
not respond to current treatments. Human trials are there-
fore required to validate these possibilities, and further
explorations into the molecular mechanisms underlying the
central effects of B-GOSs, may reveal additional pathways
through which gut bacteria influence brain function syner-
gistically with the metabolites of this prebiotic.Role of funding source
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